V026-4241 Screening compound: N-[2-(3,4-dimethoxyphenyl)ethyl]-N-(2-{[5-(4-methylphenyl)-1,3,4-thiadiazol-2-yl]carbamoyl}ethyl)dodecanamide

V026-4241 Screening compound: N-[2-(3,4-dimethoxyphenyl)ethyl]-N-(2-{[5-(4-methylphenyl)-1,3,4-thiadiazol-2-yl]carbamoyl}ethyl)dodecanamide
V026-4241 Screening compound: N-[2-(3,4-dimethoxyphenyl)ethyl]-N-(2-{[5-(4-methylphenyl)-1,3,4-thiadiazol-2-yl]carbamoyl}ethyl)dodecanamide alternative view

Chemical Structure Depiction of ChemDiv screening compound V026-4241
N-[2-(3,4-dimethoxyphenyl)ethyl]-N-(2-{[5-(4-methylphenyl)-1,3,4-thiadiazol-2-yl]carbamoyl}ethyl)dodecanamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

V026-4241

Molecular Formula

C34H48N4O4S (C34 H48 N4 O4 S)

Compound Name

N-[2-(3,4-dimethoxyphenyl)ethyl]-N-(2-{[5-(4-methylphenyl)-1,3,4-thiadiazol-2-yl]carbamoyl}ethyl)dodecanamide

IUPAC name

N-[2-(34-dimethoxyphenyl)ethyl]-N-(2-{[5-(4-methylphenyl)-134-thiadiazol-2-yl]carbamoyl}ethyl)dodecanamide

SMILES

CCCCCCCCCCCC(N(CCC(Nc1nnc(-c2ccc(C)cc2)s1)=O)CCc(cc1)cc(OC)c1OC)=O

InChI

InChI=1S/C34H48N4O4S/c1-5-6-7-8-9-10-11-12-13-14-32(40)38(23-21-27-17-20-29(41-3)30(25-27)42-4)24-22-31(39)35-34-37-36-33(43-34)28-18-15-26(2)16-19-28/h15-20,25H,5-14,21-24H2,1-4H3,(H,35,37,39)

InChI Key

DRUGZZQTLJCKBE-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD19716639

Chemical and Physical Properties

Saltdata

not_available

Molecular Weight

608.85

Hydrogen Bond Acceptors Count

8.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

22.00

Number of Nitrogen and Oxygen Atoms

8

Partition Coefficient, logP

8.080

Distribution Coefficient, logD

8.079

Water Solubility, LogSw

-5.58

Polar Surface Area

77.562

Acid Dissociation Constant (pKa)

10.55

Base Dissociation Constant (pKb)

-0.14

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

52.90

V026-4241 in Drug Discovery

Included in Screening Libraries

3CLpro Library (4801 compounds)

ACE2 Library (3043 compounds)

CORONAVIRUS Library (20774 compounds)

Regenerative Medicine Focused Library (23016 compounds)

Histone Deacetylases (HDAC) Targeted Library (9760 compounds)

Protein Tyrosine Phosphatase Non-receptor Type (PTPN) Targeted Library (32556 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Antiviral
  • Infections
  • Immune system
  • Antiviral
  • Infections
  • Immune system
  • Antiviral
  • Infections
  • Immune system
  • Musculoskeletal
  • Digestive system
  • Hemic and lymphatic
  • Cardiovascular
  • Skin
  • wounds
  • Cancer
  • Nervous system
  • Hemic and lymphatic
  • Endocrine
  • Immune system
  • Cancer
  • Nervous system
  • Male
  • Female
  • Hemic and lymphatic
  • Skin
  • Endocrine
Mechanism of action:
  • Epigenetic
Targets:
  • Phosphatases

References: we are preparing a list of scientific research reports with V026-4241 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound V026-4241?
Check Price and Availability of V026-4241, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of V026-4241 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for V026-4241
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for V026-4241
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of V026-4241 available by request